I will help ohm a little with this excellent post I just
I will help ohm a little with this excellent post I just saw…
Great post by Dante on YMB about 10k filing. Well worth reading.
Couple points (HYPOTHESIS) in regards to the sec and DOJ investigation.
1.I’m almost certain these investigations relate to the citron short attack last June. Cydy said in a conference call a year ago they where pursuing legal action.
2. if this was negatively towards cydy the cydy board would of already removed the employees.
3.they signed 3 deals with other companies this year. None of those companies would do a deal with cydy if they were under serious investigation from the United States government.
4. If cydy was being seriously investigated for wrong doing ...the 13D would be all over this. Why haven’t they said anything about this? To use it against cydy to flip the board? I’m sure members would know.....this leaves me to believe ultimately it’s about citron short attack because if 13D started bashing in sec filing and in there letters claiming wrong doing and it wasn’t...they would be sued by cydy.
5. There is no way biome would do a trial.
6. Dr.Recknor wouldn’t join the company knowing that cydy is under serious investigation for wrong doing.
7. Connect the dots. Cydy has released a 8k with every trial with all data. You think they do that for no reason other biotechs don’t do that....as soon as cd12 data was released 8k with all the data was filed. This is a company that’s almost too transparent and they get bashed for that.
8. In the letter from the fda they stated cydy is welcome to do more trials. They didn’t say they can no longer conduct covid-19 trials. If there was a sec, DOJ investigation against cydy. I’m pretty sure the fda would freeze there ability to conduct trials until the case was resolved.
9.the citron attack was illegal. Pre meditated. With a fake news report that was deleted 2 hours after posting.
10. Anything material they would have to report to shareholders. Mind you this is anything before may in a 12 month period that was 3 months ago. If it was negative towards the company we would of already known about it atleast by the end of may.
11. TI’s Reddit comment about 20minutes ago ...interesting he states something from 2019 that was 2 yrs ago about Nadar that could be under investigation for (very far fetched) and then says “but” it also could be the short attack of June 2020 they are investigating or both....HES a insider or apart of 13D He wants Nadar removed why not just say the event that happen in 2019 with out the second option of the citron short attack being the cause of the investigations....Cause he has to be very careful with his wording. (Was going to copy and paste it below) but it seems it was now been deleted......interesting.
GODSPEED. Connect the dots.
20
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Welcome to the Wild Ride of Buying a Home! When folks step into the homebuying ring, especially in places like Clermont, Florida, they often don't realize how chaotic things can get. It's like being thrown into a boxing match without gloves. Brandie Mathison-Klein from the Mathison-Klein Group shines a light on this in a HelloNation piece, spilling the beans on what...
Continue Reading
Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...
Continue Reading
Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...
Continue Reading
Shifting Sands at Sasol's Audit Helm Ah, the boardroom dance continues. Sasol has just announced, loud and clear from Johannesburg, that Mr. Stanley Subramoney is stepping up as the new Chairman of their Audit Committee. This is no small shuffle in the deck. When it comes to keeping the books in check at big players like Sasol, you need a top-tier audit leader. Ain't no...
Continue Reading
Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...
Continue Reading
IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...
Continue Reading
A Legal Storm Brews Over UP Fintech When it rains, it pours, and for UP Fintech Holding Limited, the sky's looking pretty stormy. Investors who jumped on the NASDAQ:TIGR bandwagon between April 2024 and June 2026 are finding themselves at the center of a nasty legal maelstrom. The allegations? Well, they're explosive, hinting at a pattern of unlicensed cross-border...
Continue Reading
CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...
Continue Reading
Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...
Continue Reading
Chemours Under Fire: What’s Happening? Here we are, in the thick of a legal storm surrounding The Chemours Company. A class-action lawsuit is underway, and it’s painting the company in a rather unflattering light. Now, if you snagged some of that NYSE:CC action between February 20, 2026, and August 4, 2026, there's a chance you’re caught in the crossfire. Per the...
Continue Reading
Top 5 Most Recently Viewed Articles
Cango Inc. Performs Exceptionally in Bitcoin Mining Operations Cango Inc. has seen remarkable progress in its Bitcoin mining endeavors, as showcased by its recent production report. The company operates using a well-structured strategy, which has proven successful in driving growth within the cryptocurrency market. Key Metrics to Note The September report illustrates the...
Continue Reading
BWXT's Achievement in Nuclear Fuel Deconversion Rich in innovation and commitment to nuclear solutions, BWX Technologies, Inc. (NYSE: BWXT) has recently announced a significant achievement. Their Nuclear Fuel Services, Inc. (NFS) division has been selected by the U.S. Department of Energy (DOE) as part of a prominent initiative. This recognition places BWXT at the...
Continue Reading
SEALSQ Showcases Quantum-Resistant Solutions at Quantum Days During a recent event, SEALSQ Corp (NASDAQ: LAES), a leader in semiconductor and post-quantum technology, demonstrated its commitment to cutting-edge security solutions. The event showcased live demonstrations highlighting the effectiveness of post-quantum cryptography (PQC) through their implementation of two...
Continue Reading
Ultragenyx Pharmaceutical Welcomes New Team Members Novato, California - Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a dedicated biopharmaceutical entity, proudly reports the issuance of 20,820 restricted stock units to 13 newly hired non-executive officers as part of their employment inducement initiative. This decision, approved by the company's compensation...
Continue Reading
Alto Neuroscience Faces Class Action Lawsuit for Securities Issues In recent developments, Alto Neuroscience, Inc. finds itself at the center of a class action lawsuit alleging securities fraud, with significant implications for its investors. The lawsuit, spearheaded by prominent legal firm Levi & Korsinsky, LLP, aims to secure compensation for stockholders negatively...
Continue Reading